Cencora, Inc. (COR)
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment focuses on the distribution of specialty, brand-name, and generic pharmaceuticals. The International Healthcare Solutions segment includes pharmaceutical wholesale, related operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.
Address
1 WEST FIRST AVENUE
CONSHOHOCKEN, PA 19428
Founded
1947
Number of Employees
46,000
Website
http://www.cencora.com
Buyback
Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
$ Amount Purchased ($ in 000s ) |
$848,861 | $963,449 | $1,280,881 | $269,078 | $564,375 | $644,092 | $500,476 | $55,046 | $1,359,574 | $821,341 | $604,716 | $719,263 |
Average Price | $70.15 | $92.61 | $62.31 | $67.63 | $85.18 | $82.04 | $85.02 | $111.93 | $150.48 | $189.42 | $219.02 | $94.16 |
# Shares Purchased | 12,100,927 | 10,403,024 | 20,555,638 | 3,978,391 | 6,625,695 | 7,850,754 | 5,886,246 | 491,803 | 9,035,038 | 4,336,082 | 2,760,972 | 7,638,597 |
Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Return to Date | 240.7% | 158.1% | 283.5% | 253.4% | 180.6% | 191.3% | 181.1% | 113.5% | 58.8% | 26.2% | 9.1% | 153.8% |
S&P 500 Return to Date | 181.9% | 173.0% | 168.6% | 129.7% | 104.9% | 93.1% | 74.8% | 31.7% | 37.3% | 31.3% | 7.4% | 94.0% |
Excess Total Return | 58.8% | -14.9% | 115.0% | 123.6% | 75.7% | 98.2% | 106.3% | 81.9% | 21.6% | -5.2% | 1.7% | 59.9% |
Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
Percentile Rank | 80% | 71% | 84% | 88% | 85% | 87% | 87% | 92% | 83% | 66% | 59% | 91% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)